(Q45305400)

English

Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 December 2017

Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease (English)

1 reference

Europe PubMed Central

11 December 2017

Huntington's disease

0 references

0 references

0 references

cannabinoid receptor

0 references

3

1 reference

Europe PubMed Central

11 December 2017

author name string

Lastres-Becker I

1

1 reference

Europe PubMed Central

11 December 2017

Berrendero F

2

1 reference

Europe PubMed Central

11 December 2017

Martín-Aparicio E

4

1 reference

Europe PubMed Central

11 December 2017

Yamamoto A

5

1 reference

Europe PubMed Central

11 December 2017

Ramos JA

6

1 reference

Europe PubMed Central

11 December 2017

Fernández-Ruiz JJ

7

1 reference

Europe PubMed Central

11 December 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

11 December 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

11 December 2017

929

1 reference

Europe PubMed Central

11 December 2017

2

1 reference

Europe PubMed Central

11 December 2017

236-242

1 reference

Europe PubMed Central

11 December 2017

Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Brain cannabinoid systems as targets for the therapy of neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Advances in Huntington's disease: implications for experimental therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Neuron-specific enolase (NSE) and non-neuronal enolase (NNE) mRNAs are co-expressed in neurons of the rat cerebellum: in situ hybridization histochemistry.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Ipsilateral turning behavior induced by unilateral microinjections of a cannabinoid into the rat subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and mu-opioid receptor binding in the basal ganglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Recent advances in understanding the pathogenesis of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Differential loss of striatal projection neurons in Huntington disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Activational role of cannabinoids on movement

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Role of the subthalamic nucleus in cannabinoid actions in the substantia nigra of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

delta 9-Tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903403-5

7 January 2021

Identifiers

10.1016/S0006-8993(01)03403-5

1 reference

Europe PubMed Central

11 December 2017

1 reference

Europe PubMed Central

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45305400&oldid=2074312434"